Skip to main content

Matt Mixick

Analyst

Barclays

Equibles does not estimate personal net worth.

About Matt Mixick

Matt Mixick is recorded as Analyst at Barclays. Matt Mixick has spoken on 15 earnings calls across 13 companies, most recently for Humacyte, Inc. on May 13, 2026. Those appearances were for Senseonics Holdings, Inc. (SENS), Humacyte, Inc. (HUMA), Globus Medical Inc (GMED), Alcon Inc (ALC), InMode Ltd. (INMD) and 8 other companies. The companies whose calls Matt Mixick spoke on are classified in the Healthcare sector.

Matt Mixick on recent calls

“And so I wanted to ask about the commercial efforts that you're putting in place to sort of drive greater adoption in the, I guess, the U.S. market for trauma, away from some of the government contracts that you've established, which are great.”
Analyst — Barclays, Humacyte, Inc. Q1 FY2026 Earnings Call ·
“I was wondering about just robot demand, you know, hospital investments and robot platforms.”
Analyst — Barclays, Globus Medical Inc Q1 FY2026 Earnings Call ·
“You know, I had one question on just sort of like the retention of some of the folks using the system, and then one on sort of the next-gen technology platform power enhancements that you've made.”
Analyst — Barclays, Senseonics Holdings, Inc. Q1 FY2026 Earnings Call ·
“So, listen, I appreciate the color on the market, and congrats on the progress on PanObjects Pro.”
Analyst — Barclays, Alcon Inc Q1 FY2026 Earnings Call ·
“So on ophthalmology, I was wondering if you could, and I've been hopping around here between calls, so apologies if it's already been covered, but maybe an update on, you know, how the U.S. sales reorg and management is driving that growth, what your plans are there, maybe what some of the early results you've seen…”
Analyst — Barclays, InMode Ltd. Q1 FY2026 Earnings Call ·

Affiliation history

  • Barclays

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity